UBS Group
HQH

UBS Group’s abrdn Healthcare Investors HQH Stock Holding History

UBS Group’s Portfolio HQH Stock Details HQH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
128,934
+4,752
+4% +$89.9K ﹤0.01% 4853
2025
Q4 		$2.35M Sell
124,182
-34,669
-22% -$655K ﹤0.01% 4823
2025
Q3 		$2.93M Buy
158,851
+45,704
+40% +$746K ﹤0.01% 4587
2025
Q2 		$1.75M Sell
113,147
-21,241
-16% -$329K ﹤0.01% 4953
2025
Q1 		$2.18M Sell
134,388
-15,780
-11% -$271K ﹤0.01% 4625
2024
Q4 		$2.41M Buy
150,168
+7,401
+5% +$131K ﹤0.01% 4551
2024
Q3 		$2.66M Buy
142,767
+12,936
+10% +$241K ﹤0.01% 3715
2024
Q2 		$2.27M Sell
129,831
-14,274
-10% -$238K ﹤0.01% 3645
2024
Q1 		$2.43M Buy
144,105
+7,649
+6% +$130K ﹤0.01% 3752
2023
Q4 		$2.26M Sell
136,456
-53,522
-28% -$823K ﹤0.01% 3675
2023
Q3 		$2.95M Sell
189,978
-18,159
-9% -$303K ﹤0.01% 3074
2023
Q2 		$3.55M Buy
208,137
+8,061
+4% +$140K ﹤0.01% 2920
2023
Q1 		$3.53M Sell
200,076
-6,556
-3% -$119K ﹤0.01% 2850
2022
Q4 		$3.72M Sell
206,632
-24,891
-11% -$461K ﹤0.01% 2780
2022
Q3 		$4M Sell
231,523
-29,801
-11% -$570K ﹤0.01% 2558
2022
Q2 		$4.88M Sell
261,324
-28,701
-10% -$568K ﹤0.01% 2395
2022
Q1 		$6.02M Sell
290,025
-17,025
-6% -$362K ﹤0.01% 2357
2021
Q4 		$7.3M Buy
307,050
+1,033
+0.3% +$25.7K ﹤0.01% 2440
2021
Q3 		$7.83M Buy
306,017
+19,015
+7% +$500K ﹤0.01% 2234
2021
Q2 		$7.38M Sell
287,002
-3,106
-1% -$76.6K ﹤0.01% 2299
2021
Q1 		$7.08M Buy
290,108
+9,930
+4% +$242K ﹤0.01% 2272
2020
Q4 		$6.68M Buy
280,178
+22,832
+9% +$496K ﹤0.01% 2180
2020
Q3 		$5.31M Buy
257,346
+4,245
+2% +$89.7K ﹤0.01% 2149
2020
Q2 		$5.4M Buy
253,101
+113,581
+81% +$2.32M ﹤0.01% 1981
2020
Q1 		$2.48M Buy
139,520
+6,258
+5% +$123K ﹤0.01% 2561
2019
Q4 		$2.78M Buy
133,262
+1,973
+2% +$39.1K ﹤0.01% 3215
2019
Q3 		$2.41M Sell
131,289
-6,563
-5% -$127K ﹤0.01% 3123
2019
Q2 		$2.77M Buy
137,852
+5,692
+4% +$112K ﹤0.01% 2853
2019
Q1 		$2.71M Sell
132,160
-98,494
-43% -$2.02M ﹤0.01% 2720
2018
Q4 		$4.14M Sell
230,654
-67,269
-23% -$1.38M ﹤0.01% 2328
2018
Q3 		$6.9M Sell
297,923
-20,365
-6% -$461K ﹤0.01% 2077
2018
Q2 		$6.84M Sell
318,288
-27,405
-8% -$583K ﹤0.01% 2068
2018
Q1 		$7.44M Buy
345,693
+9,520
+3% +$219K ﹤0.01% 1948
2017
Q4 		$7.58M Sell
336,173
-144,478
-30% -$3.38M ﹤0.01% 1962
2017
Q3 		$12.1M Sell
480,651
-7,954
-2% -$200K 0.01% 1460
2017
Q2 		$12.3M Buy
488,605
+126,766
+35% +$3.14M 0.01% 1373
2017
Q1 		$8.7M Sell
361,839
-16,846
-4% -$396K ﹤0.01% 1618
2016
Q4 		$8M Buy
378,685
+17,729
+5% +$395K ﹤0.01% 1694
2016
Q3 		$8.59M Buy
360,956
+8,124
+2% +$204K 0.01% 1542
2016
Q2 		$8.27M Buy
352,832
+20,366
+6% +$505K 0.01% 1533
2016
Q1 		$7.98M Sell
332,466
-35,177
-10% -$837K 0.01% 1481
2015
Q4 		$10.9M Buy
367,643
+74,851
+26% +$2.31M 0.01% 1345
2015
Q3 		$8.08M Buy
292,792
+11,497
+4% +$391K 0.01% 1553
2015
Q2 		$9.78M Buy
281,295
+18,901
+7% +$656K 0.01% 1497
2015
Q1 		$8.94M Buy
262,394
+34,903
+15% +$1.17M 0.01% 1558
2014
Q4 		$7.01M Buy
+227,491
New +$6.84M ﹤0.01% 1799

Other funds holding HQH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's HQH Position: Q1 2026 in Review

UBS Group increased its abrdn Healthcare Investors (HQH) stake by 3.8% in Q1 2026, buying an estimated $89.9K and bringing the position to 128,934 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4853.

UBS Group first reported a position in HQH in Q4 2014 and has held it in 46 quarters since. The position peaked at $12.3M in Q2 2017. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.

  • UBS Group held 128,934 shares of abrdn Healthcare Investors worth $2.29M as of Q1 2026.
  • UBS Group bought 4,752 abrdn Healthcare Investors shares in Q1 2026, an estimated $89.9K.
  • abrdn Healthcare Investors made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4853 holding.
  • UBS Group first reported a position in abrdn Healthcare Investors in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's abrdn Healthcare Investors position peaked at $12.3M in Q2 2017.
  • 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.